Cat. #161776
TOV-2414 cell line
Cat. #: 161776
Organism: Human
Tissue: Derived from solid tumor from patient of mucinous carcinoma
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Anne-Marie Mes-Masson and Diane Provencher
Institute: Centre Hospitalier de Luniversité de Montréal
Primary Citation: Sauriol A et al. 2020. Cancers. 12(8):2222. PMID: 32784519
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: TOV-2414 cell line
- Alternate name: TOV-2414
- Cancer: Gynaecologic cancer
- Research fields: Cancer
- Organism: Human
- Gender: Female
- Tissue: Derived from solid tumor from patient of mucinous carcinoma
- Donor: Grade 1 Stage IIIC; Mutations: K-RAS2; Pre-treatment
- Morphology: Stretched-like morphology
- Growth properties: Adherent
- Crispr: No
- Receptors of note: No
- Description: Epithelial ovarian cancer cell line derived from solid tumor from patient of mucinous carcinoma who was chemonaive at the time of sampling. Cell line produces tumors in mice upon SC injection
- Production details: Established using the Scrape method where tumor tissue was scraped into a 100mm plate with complete OSE medium and maintained for 40 days with medium replaced weekly.
- Additional notes: Patient 2414 was diagnosed at age 63 and had no prior cancer history. Site of sampling was the ovary and year of sampling was 2005.
Handling
- Growth medium: OSE medium contains 10% FBS, 0.5ug/mL amphotericin B and 50 ug/mL gentamicin
- Temperature: 37° C
- Atmosphere: Low oxygen conditions of 7% O2 and 5% CO2
- Cultured in antibiotics: Amphotericin B and Gentamicin
References
- Gaia-Oltean et al. 2021. Exp Ther Med. 21(3):243. PMID: 33603851 Canals Hernaez et al. 2020. J Immunother Cancer. 8(2):e001128. PMID: 33243933 Borzdzi?owska et al. 2022. Biomedicines. 11
- 10(5):1116. PMID: 35625852 Meng et al. 2023. J Anim Sci. 3
- 101:skad215. PMID: 37351870 Koni et al. 2020. Int J Mol Sci. 18
- 21(20):7697. PMID: 33080952
